Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

SHSE:603896 Stock Report

Market Cap: CN¥5.5b

Zhejiang Shouxiangu Pharmaceutical Past Earnings Performance

Past criteria checks 2/6

Zhejiang Shouxiangu Pharmaceutical has been growing earnings at an average annual rate of 22.2%, while the Personal Products industry saw earnings growing at 9.8% annually. Revenues have been declining at an average rate of 0.4% per year. Zhejiang Shouxiangu Pharmaceutical's return on equity is 11.9%, and it has net margins of 1824.3%.

Key information

22.2%

Earnings growth rate

20.7%

EPS growth rate

Personal Products Industry Growth7.8%
Revenue growth rate-0.4%
Return on equity11.9%
Net Margin1,824.3%
Last Earnings Update31 Mar 2024

Recent past performance updates

Weak Statutory Earnings May Not Tell The Whole Story For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896)

May 02
Weak Statutory Earnings May Not Tell The Whole Story For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896)

Recent updates

Weak Statutory Earnings May Not Tell The Whole Story For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896)

May 02
Weak Statutory Earnings May Not Tell The Whole Story For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896)

Revenue & Expenses Breakdown
Beta

How Zhejiang Shouxiangu Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:603896 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 241526941250
31 Dec 23025440550
30 Sep 2386428741250
30 Jun 2385128640647
31 Mar 2383228140148
31 Dec 2282927840748
30 Sep 2279524439854
30 Jun 2279922841056
31 Mar 2279721940953
31 Dec 2176720139851
30 Sep 2172217239652
30 Jun 2171716438849
31 Mar 2167716036846
31 Dec 2063615233748
30 Sep 2059713432943
30 Jun 2052911929842
31 Mar 2051411329141
31 Dec 1954712431339
30 Sep 1953110532041
30 Jun 1953910033238
31 Mar 1955011533535
31 Dec 1851110830934
30 Sep 184619828131
30 Jun 1843010224735
31 Mar 1840910023230
31 Dec 173708921421
30 Sep 173428919310
30 Jun 17333852000
31 Mar 17317841870
31 Dec 16315811880
31 Dec 15302631780
31 Dec 14302691490
31 Dec 13253541060

Quality Earnings: 603896 has a high level of non-cash earnings.

Growing Profit Margin: 603896's current net profit margins are higher than last year (33.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 603896's earnings have grown significantly by 22.2% per year over the past 5 years.

Accelerating Growth: 603896's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 603896 had negative earnings growth (-4.4%) over the past year, making it difficult to compare to the Personal Products industry average (-0.2%).


Return on Equity

High ROE: 603896's Return on Equity (11.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.